Microlife Wins Accolades from Frost & Sullivan for its Unique Automated Oscillometric Blood Pressure Monitor

LONDON, Dec. 10, 2013 /PRNewswire/ -- Based on its recent research on the blood pressure monitoring market, Frost & Sullivan presents Microlife Corporation (Microlife) with the 2013 European Frost & Sullivan Award for Competitive Strategy Innovation & Leadership. Microlife has strategically invested in R&D to address the unmet needs of a large patient base for the diagnosis of atrial fibrillation. It recently launched Watch BP Home A, an automated oscillometric blood pressure monitor equipped with an accurate atrial fibrillation detection system. The device is used at the initial level of screening for cardiovascular disorders such as hypertension and atrial fibrillation.

The Watch BP Home A detects atrial fibrillation based on an embedded algorithm that calculates the irregularity index (standard deviation divided by the mean), depending on the intervals between heartbeats. The diagnosis is further confirmed by performing an electrocardiogram (ECG); "Microlife has astutely positioned the Watch BP Home A as a blood pressure monitor, with atrial fibrillation detection merely being an additional feature, it is this feature that has promoted its acceptance and adoption in the clinical community," said Frost & Sullivan Senior Research Analyst Akanksha Joshi.

Measuring blood pressure, while simultaneously detecting atrial fibrillation, helps reducing the number of strokes and eventually saves costs. According to Frost & Sullivan there is rising competition among companies to provide devices at the lowest possible price. This adversely affects profitability and reduces manufacturers' ability to invest significantly in R&D.

In such a competitive market, Microlife stands out for the diagnostic accuracy of Watch BP Home A, which has been clinically investigated by several studies. The Microlife brand received a huge boost with the world-renowned National Institute for Health and Care Excellence (NICE) recommending the device for routine blood pressure measurement and atrial fibrillation screening in primary care.

The Watch BP Home A follows the European Society of Hypertension (ESH) and American Heart Association (AHA) recommendations for home blood pressure measurement, being the first of its kind. These recommendations by reputed organizations add credibility to the product and clearly enhance its brand value. "Frost & Sullivan believes that in comparison to competitors, Microlife possesses an exceptional ability to understand market conditions and gaps," noted Joshi. "The Watch BP monitor is a manifestation of Microlife's best practices and has enhanced the company's market value."

Each year, Frost & Sullivan presents this award to the company that has leveraged competitive intelligence to successfully execute a strategy that results in stronger market share, competitive brand positioning and customer satisfaction.

Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Microlife

Founded in 1981, Microlife is one of the world leaders in the development and manufacturing of medical diagnostic equipment for home monitoring and professional use. Not just one of two major brands worldwide supplier of electronic blood pressure measurement products, but also the world's largest digital temperature measurement products supplier. Microlife is not just aiming to develop new devices. By integrating cutting-edge medical technology into our devices to meet people's health needs, Microlife provides solutions to meet the needs of physicians, healthcare providers, and their busy practices. We invite you to join us and make a big stride - Empowering people to manage and promote their own health. For more information, please visit: www.microlife.com

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

• The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
• The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:        Gain access to visionary innovation

Contact:

Emily Bailey
Frost & Sullivan
[email protected]
P: +44 (0)20 7915 7869
www.frost.com

SOURCE Frost & Sullivan